Company Filing History:
Years Active: 2021-2025
Title: Innovations by Patricia Cogram in Therapeutic Compounds
Introduction
Patricia Cogram is an accomplished inventor based in Oxford, GB. She has made significant contributions to the field of therapeutic compounds, particularly in the treatment of neurological disorders. With a total of 2 patents, her work focuses on innovative solutions for conditions such as Pitt Hopkins syndrome and autism.
Latest Patents
Cogram's latest patents include groundbreaking inventions aimed at addressing serious health issues. The first patent involves "Bicyclic compounds and methods for their use in treating Pitt Hopkins syndrome." This invention provides compounds, compositions, methods, and uses for therapeutic diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds. These innovations are designed to treat Pitt Hopkins Syndrome and its symptoms, as well as to manufacture various formulations such as tablets, capsules, liquid formulations, gels, and injectable solutions.
The second patent focuses on "Bicyclic compounds and methods for their use in treating autism." Similar to her first patent, this invention offers compositions and methods for the therapeutic use of diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds. These formulations aim to alleviate symptoms of Autistic Disorder or Autism, providing a range of medicaments for effective treatment.
Career Highlights
Patricia Cogram is associated with Neuren Pharmaceuticals Limited, where she continues to develop her innovative ideas into practical applications. Her work is pivotal in advancing therapeutic options for patients suffering from complex neurological conditions.
Collaborations
Cogram collaborates with notable professionals in her field, including Lawrence Irwin Glass and Michael John Bickerdike. These partnerships enhance her research and development efforts, contributing to the success of her inventions.
Conclusion
Patricia Cogram's contributions to the field of therapeutic compounds demonstrate her commitment to improving the lives of individuals with neurological disorders. Her innovative patents reflect a significant advancement in medical science, paving the way for new treatment options.